Dublin, Ireland

Anne Marie Healy

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Trinity College Dublin, University of College Dublin. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Marie Healy. Retrieved from https://idiyas.com/inventor/anne-marie-healy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anne Marie Healy - Innovator in Microparticle Technology.

Introduction

Anne Marie Healy is an inventor based in Castleknock, Ireland. She has made significant contributions to the field of microparticle technology. Her innovative approach focuses on the production of porous microparticles, which have various applications in pharmaceuticals and bioactive compounds.

Latest Patent Applications

Anne Marie Healy's notable patent application is titled "Method of producing porous microparticles." This method involves combining one or more organic compounds with a volatile solvent system. The system is then spray dried to create porous microparticles of the organic compound or composite porous microparticles of combinations of organic compounds. The organic compounds used in this method may include bioactives, pharmaceutically acceptable excipients, and adjuvants, among others.

Conclusion

Anne Marie Healy's work in developing methods for producing porous microparticles showcases her innovative spirit and dedication to advancing technology in the pharmaceutical field. Her contributions are poised to impact various applications in medicine and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…